Grifols (GIFLF) Gains from Sales and Divestitures (2013 - 2015)
Grifols' (GIFLF) quarterly Gains from Sales and Divestitures came in at $4.8 million in Q3 2015, up 90.26% on a YoY basis from $2.5 million in Q3 2014, and up 526.42% quarter-over-quarter from $764757.8 in Q2 2015.
Analysis
Grifols (GIFLF) Gains from Sales and Divestitures (2013 - 2015) Analysis & Trends
Grifols (GIFLF) has reported Gains from Sales and Divestitures for 3 consecutive years, with $4.8 million the latest figure, recorded in Q3 2015.
- For the quarter ending Q3 2015, Gains from Sales and Divestitures rose 90.26% year-over-year to $4.8 million; the trailing twelve-month figure through Sep 2015 stood at $8.7 million (up 263.78% YoY), and the FY2012 full-year result was $16.1 million, down 40.19% from the prior year.
- Gains from Sales and Divestitures grew to $4.8 million in Q3 2015 per GIFLF's latest filing, from $764757.8 in the prior quarter.
- Across five years, Gains from Sales and Divestitures topped out at $4.8 million in Q3 2015 and bottomed at -$2.6 million in Q1 2014.
- Historically, Gains from Sales and Divestitures has averaged $1.5 million across 3 years, with a median of $1.2 million in 2013.
- The widest YoY moves for Gains from Sales and Divestitures: up 809.2% in 2014, down 172.57% in 2014.
- Over 3 years, Gains from Sales and Divestitures stood at $276933.1 in 2013, then soared by 809.2% to $2.5 million in 2014, then jumped by 90.26% to $4.8 million in 2015.
- According to Business Quant data, Gains from Sales and Divestitures over the past three periods registered $4.8 million, $764757.8, and $581863.7 for Q3 2015, Q2 2015, and Q1 2015 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 203.97 Bn | 189.99 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 178.74 Bn | 175.56 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.73 Bn | 122.88 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 80.42 Bn | 72.42 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.40 Bn | 55.21 Bn | 1.37 Bn |
| 6 | Moderna | 57.65 Bn | 52.52 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.37 Bn | 30.07 Bn | 992.69 Mn |
| 8 | Biogen | 32.15 Bn | 30.86 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.58 Bn | 29.58 Bn | 1.16 Mn |
| 10 | Grifols | 7.54 Bn | 9.09 Bn | 3.33 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2015 | 4.79 Mn |
| Jun 30, 2015 | 764,757.76 |
| Mar 31, 2015 | 581,863.73 |
| Sep 30, 2014 | 2.52 Mn |
| Jun 30, 2014 | 2.19 Mn |
| Mar 31, 2014 | -2.60 Mn |
| Sep 30, 2013 | 276,933.07 |
| Jun 30, 2013 | 1.25 Mn |
| Mar 31, 2013 | 3.59 Mn |